Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-223545
Filing Date
2017-07-07
Accepted
2017-07-07 06:07:32
Documents
4
Period of Report
2017-07-04

Document Format Files

Seq Description Document Type Size
1 6-K d418035d6k.htm 6-K 9009
2 EX-99.1 d418035dex991.htm EX-99.1 152461
3 GRAPHIC g418035g04y43.jpg GRAPHIC 2919
4 GRAPHIC g418035g68v82.jpg GRAPHIC 9646
  Complete submission text file 0001193125-17-223545.txt   179994
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 17953767
SIC: 2834 Pharmaceutical Preparations